Clinicians do not answer cold pitches and life-science sponsors sit behind incumbents. We build the list from evidence — registries, licences, trial activity — and open the conversation where the buyer already trusts the room.
NPI registrations, state licensing boards, CMS data and ClinicalTrials.gov show who is opening sites, adding providers or starting trials. We build the list from that, not from a database guess.
A clinician uses it, a practice administrator signs it, and IT and compliance can stop it. Each gets outreach written for what they care about.
HIPAA, BAAs and peer proof come before features. We reach clinicians through specialty associations, conferences and communities they already trust.
A bootstrapped AI dictation product plateaued at $5k MRR on inbound alone. An ICP correction and a trust-first channel surfaced up to 2,000 potential licenses inside six weeks, with conversations still underway.
Large sponsors were locked into incumbents. Joining a paid database against a free federal registry produced a list where every account had already proven it needed the product.